FdaApplication
BLA 021859
Identifiers
- fda_app_no: BLA021859
Properties
| Property | Value |
|---|---|
| applicant_name | Halozyme Therapeutics, Inc. |
| application_type | BLA |
| approval_date | 2005-12-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYLENEX RECOMBINANT | HYALURONIDASE RECOMBINANT HUMAN | 150UNITS/ML | Injection |
1 product